Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Debt / NOTE 2.250% 3/0
-
Number of holders
-
25
-
Total 13F principal, excl. options
-
302,278,349
-
Principal change
-
+302,278,349
-
Total reported value, excl. options
-
$747,951,345
-
Value change
-
+$747,952,452
-
Number of buys
-
25
-
Price
-
$1.06
Institutional Holders of TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 as of Q1 2022
As of 31 Mar 2022 TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 had 25 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $302,278,349 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included PERCEPTIVE ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, D. E. Shaw & Co., Inc., LAZARD ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, CITADEL ADVISORS LLC, Linden Advisors LP, CAPSTONE INVESTMENT ADVISORS, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and Polar Asset Management Partners Inc..
This table shows 25 bond principal holders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.